Cargando…

Microbiota and Graft-versus Host disease: a double-edged sword

Detalles Bibliográficos
Autores principales:	Holler, Ernst, Weber, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Stem cell transplantation - Section 17
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925663/ https://www.ncbi.nlm.nih.gov/pubmed/35309821 http://dx.doi.org/10.1097/HS9.0000000000000204

Ejemplares similares

Medical management of acute responses to radiation
por: Chao, Nelson J., et al.
Publicado: (2019)

Unmanipulated haploidentical transplantation for adult patients with hematological malignancies
por: Ruggeri, Annalisa, et al.
Publicado: (2019)

siRNA against CD40 delivered via a fungal recognition receptor ameliorates murine acute graft‐versus‐host disease
por: Heissig, Beate, et al.
Publicado: (2022)

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
por: Akahoshi, Yu, et al.
Publicado: (2022)

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
por: Al Malki, Monzr M., et al.
Publicado: (2023)

MicroRNA serum profiles and chronic graft-versus-host disease
por: Reikvam, Håkon, et al.
Publicado: (2022)

Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease
por: Martin, Paul J., et al.
Publicado: (2021)

Evidence-based, Skin-directed Treatments for Cutaneous Chronic Graft-versus-host Disease
por: Kim, Yoo Jung, et al.
Publicado: (2019)

Prediction of outcomes after second-line treatment for acute graft-versus-host disease
por: Vo, Phuong, et al.
Publicado: (2022)

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
por: Robin, Marie, et al.
Publicado: (2022)

SALIVA VERSUS SECREÇÃO ORO-NASOFARÍNGEA PARA A DETECÇÃO MOLECULAR DE SARS-COV-2 E SUA CORRELAÇÃO COM O STATUS CLÍNICO E VACINAL
por: Furtado, Fabiana Barcelos, et al.
Publicado: (2022)

Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival
por: Pidala, Joseph, et al.
Publicado: (2021)

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
por: Pratta, Michael, et al.
Publicado: (2022)

Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease
por: Shrestha, Pradeep, et al.
Publicado: (2023)

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
por: Cutler, Corey, et al.
Publicado: (2021)

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression
por: Zhu, Jingru, et al.
Publicado: (2022)

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
por: Cuvelier, Geoffrey D. E., et al.
Publicado: (2022)

Deubiquitinase OTUD3: a double-edged sword in immunity and disease
por: Xu, Qiao, et al.
Publicado: (2023)

DNA Double-Strand Breaks: A Double-Edged Sword for Trypanosomatids
por: da Silva, Marcelo Santos
Publicado: (2021)

Stem cell transplantation
por: Schaap, Nicolaas
Publicado: (2019)

The microbiota and chronic kidney diseases: a double-edged sword
por: Felizardo, Raphael Jose Ferreira, et al.
Publicado: (2016)

Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
por: Zhou, Fangli, et al.
Publicado: (2021)

The Peroxisome-Autophagy Redox Connection: A Double-Edged Sword?
por: Li, Hongli, et al.
Publicado: (2021)

Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
por: Kim, Haesook T., et al.
Publicado: (2022)

Double-edged sword.
Publicado: (1994)

Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger
por: Azem, Amin, et al.
Publicado: (2022)

Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
por: Socié, Gerard, et al.
Publicado: (2023)

Defensins: A Double-Edged Sword in Host Immunity
por: Xu, Dan, et al.
Publicado: (2020)

Transgelin-2: A Double-Edged Sword in Immunity and Cancer Metastasis
por: Kim, Hye-Ran, et al.
Publicado: (2021)

Autophagy and Mitochondrial Homeostasis During Infection: A Double-Edged Sword
por: Wang, Sutian, et al.
Publicado: (2021)

The Endothelial Glycocalyx as a Double-Edged Sword in Microvascular Homeostasis and Pathogenesis
por: Villalba, Nuria, et al.
Publicado: (2021)

Early Report on COVID-19 Infections in Pediatric Heart Transplant Recipients and Candidates
por: Conway, J., et al.
Publicado: (2021)

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis
por: Roy, Denis Claude, et al.
Publicado: (2019)

Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience
por: Hashmi, Hamza, et al.
Publicado: (2020)

The double-edged sword of evolution
por: Kruzel-Davila, Etty, et al.
Publicado: (2017)

A double-edged sword
por: Vandebotermet, Martijn, et al.
Publicado: (2020)

Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience
por: Kaufman, Stuart S., et al.
Publicado: (2021)

CDKN1A: A double-edged sword in fatty liver?
por: Valenti, Luca, et al.
Publicado: (2014)

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
por: Alfred, Arun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fkbbl698h95ui2ibvp7r7i1he8